A re ‐appraisal of the benefit‐risk profile of Hydroxyurea in polycythemia vera: A propensity‐matched study

In conclusion, this analysis provides reliable and qualified estimates of the therapeutic profile of HU and PHL treatments for future experimental studies and for the management of PV in clinical practice. This article is protected by copyright. All rights reserved.

Source: American Journal of Hematology - July 11, 2017 Category: Hematology Authors: Tiziano Barbui, Alessandro M Vannucchi, Guido Finazzi, Maria Chiara Finazzi, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Gianni Tognoni Tags: Research Article Source Type: research